VeriMomVeriMom
HIGH RISK

임신 중 ci 77947을 피해야 할까요? | VeriMom

Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.

ECHA regulatory hazard statements

  • H400
  • H410

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

ci 77947은 임신 중 안전한가요?
Zinc oxide (CI 77947, CAS 1314-13-2) has no harmonised reproductive classification (ECHA Annex VI lists only environmental classifications H400/H410). Authoritative cosmetic panels (e.g., SCCS/CIR) regard zinc oxide as safe for topical use in cosmetics/sunscreens under their conditions; systemic dermal absorption is minimal, so reproductive hazard and exposure during pregnancy are not indicated. Note: some non‑harmonised notifications (e.g., aggregated PubChem GHS entries) include H361, but these are self-notifications/aggregations and are not harmonised and thus do not override higher-priority sources.
ci 77947은 모유 수유 중 안전한가요?
Because dermal/systemic absorption of zinc oxide from topical formulations is negligible under normal use (per SCCS/CIR assessments), maternal systemic exposure that could transfer to breast milk is not expected. No authoritative evidence of reproductive/lactational toxicity from harmonised classifications.
ci 77947은 아기 피부에 안전한가요?
Hazard and mechanism: no infant-specific reproductive/toxic mechanism identified. Exposure: while adult dermal absorption is negligible, zinc oxide is not absolutely non-absorbable and infants (0–3 yr) have an immature skin barrier/higher surface‑area‑to‑body‑weight, so exposure score is increased by +1 relative to adults. SCCS/CIR accept topical use (including in sunscreens and barrier creams) given minimal systemic uptake, but infant-specific absorption data are limited.
VeriMom은 ci 77947을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 ci 77947을 39/100 (높은 위험)로 평가합니다.
임신 중 ci 77947 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요